Spencer Streit, D.O., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist and Hematologist - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Spencer Streit, D.O., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist and Hematologist

 Board-certified medical oncologist and hematologist Spencer Streit, D.O., has joined the Eugene M. and Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital.

  • By

  • September 3, 2026

  • 2 min

Share

Clinical Scorecard: Spencer Streit, D.O., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist and Hematologist

At a Glance

CategoryDetail
ConditionCancer Care
Key MechanismsEvidence-based, personalized cancer care and multidisciplinary collaboration
Target PopulationPatients with solid tumors, particularly gastrointestinal cancers
Care SettingMultidisciplinary cancer care team at Lynn Cancer Institute

Key Highlights

  • Board-certified medical oncologist and hematologist
  • Special interest in gastrointestinal cancers
  • Completed hematology-oncology fellowship at Memorial Healthcare System
  • Contributed to research on gastric adenocarcinoma and targeted therapies
  • Fluent in English

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients with cancer

          Focus on compassionate, patient-centered care throughout the cancer journey

          Clinical Best Practices

          • Multidisciplinary collaboration in cancer care
          • Support for patients and their families during treatment

          Related Resources & Content

            Original Source(s)

            Spencer Streit, D.O., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist and Hematologist

            • by

            • September 3, 2026

            Related Content

            Trastuzumab deruxtecan treatment for HER2-low metastatic scrotal extramammary Paget’s disease with bone marrow involvement: a case report

            Correction: Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer

            Statins use and prognosis in lung cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis